Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Alicia, Gómez Yafal"'
Autor:
Kimberly A. Zinnack, Norman L. Letvin, Kristin Beaudry, Alicia Gómez Yafal, Petr O. Ilyinskii, Dennis Panicali, Kelledy Manson, Shawn S. Jackson, Valerie Philippon, Marcelo J. Kuroda, Linda Gritz, Michelle A. Lifton, Gail P. Mazzara
Publikováno v:
Journal of Virology. 79:6554-6559
Poxvirus vaccine vectors, although capable of eliciting potent immune responses, pose serious health risks in immunosuppressed individuals. We therefore constructed five novel recombinant vaccinia virus vectors which contained overlapping deletions o
Autor:
Herman F. Staats, Alicia Gómez Yafal, Sushila K. Nordone, Norman L. Letvin, Barton F. Haynes, Hua-Xin Liao, Shawn S. Jackson, James W. Peacock, Linda Gritz, Gail P. Mazzara
Publikováno v:
Journal of Virology. 78:13163-13172
Induction of mucosal anti-human immunodeficiency virus type 1 (HIV-1) T-cell responses in males and females will be important for the development of a successful HIV-1 vaccine. An HIV-1 envelope peptide, DNA plasmid, and recombinant modified vaccinia
Publikováno v:
Cellular Immunology. 222:45-57
The role of OX40L on the activation of T cells was investigated using poxvirus vectors expressing OX40L alone or in combination with three other T-cell costimulatory molecules: B7-1, ICAM-1, and LFA-3. Poxvirus vector-infected cells were used to stim
Publikováno v:
Nature biotechnology. 30(7)
Academic researchers often need to stand out to advance, but the corporate world calls for team players. Moving from one world to the other can be a culture shock.
Autor:
Lynette C. Cook, Michael A. Jones, Angela W. Norton, Paolo Martini, Sarah M. Peterson, Michael W. Heartlein, Michael F. Concino, Andrea Iskenderian, Alla Romashko, Kristen Tobin, Alicia Gómez-Yafal, Lucy Liaw
Publikováno v:
BMC Cancer
BMC Cancer, Vol 10, Iss 1, p 427 (2010)
BMC Cancer, Vol 10, Iss 1, p 427 (2010)
Background Extracellular human sulfatases modulate growth factor signaling by alteration of the heparin/heparan sulfate proteoglycan (HSPG) 6-O-sulfation state. HSPGs bind to numerous growth factor ligands including fibroblast growth factors (FGF), e
Autor:
Jarasvech Chinsangaram, Claudia Palena, Dennis L. Panicali, James W. Hodge, Kenneth A. Foon, Jeffrey Schlom, Kwong Y. Tsang, Alicia Gómez Yafal
Chronic lymphocytic leukemia (CLL) is a disease of CD5+ B lymphocytes (designated as CLL cells) that are inefficient antigen-presenting cells. Their poor ability to present antigens to the T cells, largely due to an inadequate costimulatory capacity,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::628938c64496828a90b2e498db05feae
https://europepmc.org/articles/PMC1895050/
https://europepmc.org/articles/PMC1895050/
Autor:
Kwong Y. Tsang, Linda Gritz, Dennis Panicali, Gail P. Mazzara, Claudia Palena, Alicia Gómez Yafal, James L. Gulley, Kelledy Manson, Sandra Ogueta, Jeffrey Schlom, Patricia Greenhalgh, Philip M. Arlen, Junko Yokokawa
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 11(4)
Purpose: The poor immunogenicity of tumor antigens and the antigenic heterogeneity of tumors call for vaccine strategies to enhance T-cell responses to multiple antigens. Two antigens expressed noncoordinately on most human carcinomas are carcinoembr
Autor:
James W, Hodge, Diane J, Poole, Wilhelmina M, Aarts, Alicia, Gómez Yafal, Linda, Gritz, Jeffrey, Schlom
Publikováno v:
Cancer research. 63(22)
Cancer vaccine regimens use various strategies to enhance immune responses to specific tumor-associated antigens (TAAs), including the increasing use of recombinant poxviruses [vaccinia (rV) and fowlpox (rF)] for delivery of the TAA to the immune sys
Autor:
Alicia Gómez Yafal, Douglas W. Grosenbach, James W. Hodge, Jeffrey Schlom, Ariel N. Rad, Linda Gritz, Helen Sabzevari
Publikováno v:
Journal of the National Cancer Institute. 92(15)
Background: Activation and proliferation of T cells are essential for a successful cellular immune response to an antigen. Antigen-presenting cells (APCs) activate T cells through a two-signal mechanism. The first signal is antigen specific and cause
Publikováno v:
Nature Biotechnology; Jul2012, Vol. 30 Issue 7, p585-587, 3p, 1 Chart